Your browser doesn't support javascript.
loading
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.
Shah, Jatin J; Jakubowiak, Andrzej J; O'Connor, Owen A; Orlowski, Robert Z; Harvey, R Donald; Smith, Mitchell R; Lebovic, Daniel; Diefenbach, Catherine; Kelly, Kevin; Hua, Zhaowei; Berger, Allison J; Mulligan, George; Faessel, Hélène M; Tirrell, Stephen; Dezube, Bruce J; Lonial, Sagar.
Afiliação
  • Shah JJ; Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. jjshah@mdanderson.org.
  • Jakubowiak AJ; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
  • O'Connor OA; Center for Lymphoid Malignancies, Columbia University Medical Center, New York, New York.
  • Orlowski RZ; Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Harvey RD; Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Smith MR; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Lebovic D; Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.
  • Diefenbach C; New York University School of Medicine, NYU Perlmutter Cancer Center, New York, New York.
  • Kelly K; Department of Medicine, University of Southern California, Los Angeles, California.
  • Hua Z; Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts.
  • Berger AJ; Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts.
  • Mulligan G; Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts.
  • Faessel HM; Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts.
  • Tirrell S; Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts.
  • Dezube BJ; Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts.
  • Lonial S; Winship Cancer Institute, Emory University, Atlanta, Georgia.
Clin Cancer Res ; 22(1): 34-43, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26561559
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Ubiquitinas / Ciclopentanos / Terapia de Alvo Molecular / Linfoma / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Ubiquitinas / Ciclopentanos / Terapia de Alvo Molecular / Linfoma / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article